Advantage Risk Management Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Advantage Risk Management's earnings have been declining at an average annual rate of -11.6%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 7.2% per year. Advantage Risk Management's return on equity is 13.8%, and it has net margins of 7.2%.
Belangrijke informatie
-11.6%
Groei van de winst
-11.2%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 7.9% |
| Inkomstengroei | 7.2% |
| Rendement op eigen vermogen | 13.8% |
| Nettomarge | 7.2% |
| Volgende winstupdate | 14 Nov 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Advantage Risk Management geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 7,076 | 513 | 4,221 | 0 |
| 31 Mar 24 | 6,998 | 505 | 4,194 | 0 |
| 31 Dec 23 | 6,856 | 476 | 4,124 | 0 |
| 30 Sep 23 | 6,653 | 439 | 4,055 | 0 |
| 30 Jun 23 | 6,513 | 383 | 4,056 | 0 |
| 31 Mar 23 | 6,405 | 377 | 4,007 | 0 |
| 31 Dec 22 | 6,224 | 206 | 4,007 | 0 |
| 30 Sep 22 | 6,074 | 213 | 3,968 | 0 |
| 30 Jun 22 | 5,915 | 216 | 3,895 | 0 |
| 31 Mar 22 | 5,792 | 201 | 3,866 | 0 |
| 31 Dec 21 | 5,622 | 268 | 3,793 | 0 |
| 30 Sep 21 | 5,623 | 356 | 3,689 | 0 |
| 30 Jun 21 | 5,563 | 437 | 3,595 | 0 |
| 31 Mar 21 | 5,452 | 496 | 3,475 | 0 |
| 31 Dec 20 | 5,378 | 538 | 3,313 | 0 |
| 30 Sep 20 | 5,256 | 526 | 3,254 | 0 |
| 30 Jun 20 | 5,269 | 580 | 3,175 | 0 |
| 31 Mar 20 | 5,263 | 639 | 3,092 | 0 |
| 31 Dec 19 | 5,147 | 636 | 3,072 | 0 |
| 30 Sep 19 | 5,086 | 648 | 2,993 | 0 |
| 30 Jun 19 | 4,992 | 637 | 2,934 | 0 |
| 31 Mar 19 | 4,897 | 614 | 2,907 | 0 |
| 31 Dec 18 | 4,779 | 593 | 2,858 | 0 |
| 30 Sep 18 | 4,619 | 573 | 2,767 | 0 |
| 30 Jun 18 | 4,533 | 543 | 2,728 | 0 |
| 31 Mar 18 | 4,482 | 564 | 2,663 | 0 |
| 31 Dec 17 | 4,406 | 563 | 2,579 | 0 |
| 30 Sep 17 | 4,297 | 514 | 2,554 | 0 |
| 30 Jun 17 | 4,189 | 545 | 2,438 | 0 |
| 31 Mar 17 | 3,964 | 424 | 2,408 | 0 |
| 31 Dec 16 | 3,641 | 342 | 2,274 | 0 |
| 30 Sep 16 | 3,294 | 236 | 2,163 | 0 |
| 30 Jun 16 | 3,010 | 155 | 2,062 | 0 |
| 31 Mar 16 | 2,857 | 164 | 1,902 | 0 |
| 31 Dec 15 | 2,824 | 151 | 1,847 | 0 |
| 30 Sep 15 | 2,824 | 171 | 1,820 | 0 |
| 30 Jun 15 | 2,775 | 163 | 1,807 | 0 |
| 31 Mar 15 | 2,727 | 158 | 1,780 | 0 |
| 31 Dec 14 | 2,723 | 171 | 1,744 | 0 |
| 30 Sep 14 | 2,708 | 164 | 1,712 | 0 |
| 30 Jun 14 | 2,706 | 152 | 1,691 | 0 |
| 31 Mar 14 | 2,689 | 124 | 1,689 | 0 |
| 31 Dec 13 | 2,671 | 115 | 1,698 | 0 |
Kwaliteitswinsten: 8769 has high quality earnings.
Groeiende winstmarge: 8769's current net profit margins (7.2%) are higher than last year (5.9%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 8769's earnings have declined by 11.6% per year over the past 5 years.
Versnelling van de groei: 8769's earnings growth over the past year (33.9%) exceeds its 5-year average (-11.6% per year).
Winst versus industrie: 8769 earnings growth over the past year (33.9%) exceeded the Healthcare industry 9.6%.
Rendement op eigen vermogen
Hoge ROE: 8769's Return on Equity (13.8%) is considered low.